Clinical Trials Browser

Interventional × Brain Neoplasms × toripalimab × Clear all

NCT05021328 2025-02-07

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Phase 1 Completed

Brain Neoplasms